A coating composition containing a crosslinkable coating composition. The coating system comprises: ingredient A that has at least two protons that can be activated to form a Michael carbanion donor; ingredient B that functions as a Michael acceptor having at least two ethylenically unsaturated functionalities each activated by an electron-withdrawing group; and a catalyst system. In one embodiment, the catalyst system comprises diethyl carbonate, quaternary ammonium hydroxide or quaternary ammonium alkoxide, ethanol and 4-6 wt. % water. In another embodiment, the catalyst system comprises carbon dioxide, quaternary ammonium hydroxide or quaternary ammonium alkoxide, ethanol and 2-4 wt. % water. In certain embodiments, the coating composition optionally further comprising ammonium carbamate (H.sub.2NR.sub.8R.sub.9+—OC═ONR.sub.8R.sub.9), wherein R.sub.8 R.sub.9 are each independently selected from hydrogen, a linear or branched substituted or unsubstituted alkyl group having 1 to 22 carbon atoms; 1 to 8 carbon atoms; 1 to 3 carbon atoms.

The present application relates to perfume raw materials, perfumes, perfume delivery systems and consumer products comprising such perfume raw materials, perfumes and/or such perfume delivery systems, as well as processes for making and using such perfume raw materials, perfume delivery systems and consumer products. The perfumes disclosed herein expand the perfume communities' options.

Disclosed are methods of preparing thiol keratin-containing materials, comprising applying a mixture comprising one or more thiol compounds and a catalyst. Methods of preparing cross-linked keratin-containing materials by applying a mixture comprising one or more thiol compounds and an oxidizing agent are also disclosed. Methods of grafting monomeric and polymeric materials on keratin-containing materials to provide a covalent coating on keratin-containing materials are disclosed. A mixture comprising one or more thiol compounds is applied to the keratin-containing material sample. The keratin-containing material sample then comprises a plurality of free thiol groups. A monomer is optionally applied to the keratin-containing material sample to form a plurality of covalent bonds between the free thiol groups and the monomers. The disclosed grafting methods can be carried out with or without catalyst.

The invention relates to the use of lipooxigenase inhibitors for treating acne, particularly inflammatory acne. The inventive lipooxigenase inhibitor can be used alone or in combination with other lipooxigenase inhibitors or anti-acne active agents in a pharmaceutically suitable composition, particularly through oral and/or local-topic application.

The present invention includes compounds useful as modulators of TRPM8, such as compounds of Formula (I) and the subgenus and species thereof; personal products containing those compounds; and the use of those compounds and the personal products, particularly the use of increasing or inducing chemesthetic sensations, such as cooling or cold sensations. ##STR00001##

The present application relates to perfume raw materials, perfumes, perfume delivery systems and consumer products comprising such perfume raw materials, perfumes and/or such perfume delivery systems, as well as processes for making and using such perfume raw materials, perfume delivery systems and consumer products. The perfumes disclosed herein expand the perfume communities' options.

The present invention relates to a cosmetic preparation containing 4-(tert.-butyl)-4-methoxydibenzoylmethane which is encapsulated with cellulose acetate, and to methods and uses of 4-(tert.-butyl)-4-methoxydibenzoylmethane which is encapsulated with cellulose acetate.

The invention relates to the use of an agent and a composition, respectively, comprising the following active ingredients: a) an aromatase inhibitor and/or a 5--reductase inhibitor, b) an antioxidant, and c) hyaluronic acid for cosmetic purposes.

The present invention relates to bumetanide derivatives of formula (I) as well as pharmaceutical compositions comprising these compounds for use in the treatment or prevention of diseases/disorders involving Na.sup.+K.sup.+2Cl.sup.-cotransporters (NKCCs), and particularly for use in the treatment or prevention of hyperhidrosis.

##STR00001##

A coating composition containing a crosslinkable coating composition. The coating system comprises: ingredient A that has at least two protons that can be activated to form a Michael carbanion donor; ingredient B that functions as a Michael acceptor having at least two ethylenically unsaturated functionalities each activated by an electron-withdrawing group; and a catalyst system. In one embodiment, the catalyst system comprises diethyl carbonate, quaternary ammonium hydroxide or quaternary ammonium alkoxide, ethanol and 4-6 wt. % water. In another embodiment, the catalyst system comprises carbon dioxide, quaternary ammonium hydroxide or quaternary ammonium alkoxide, ethanol and 2-4 wt. % water. In certain embodiments, the coating composition optionally further comprising ammonium carbamate (H.sub.2NR.sub.8R.sub.9+OCONR.sub.8R.sub.9), wherein R.sub.8R.sub.9 are each independently selected from hydrogen, a linear or branched substituted or unsubstituted alkyl group having 1 to 22 carbon atoms; 1 to 8 carbon atoms; 1 to 3 carbon atoms.